Tian Li

Ms. Tian Li


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 January 2018 in Trials
Verified
Journal Article
Open access
PDF file
TLTian Li
Tian Li
LCLiming Chen
Liming Chen
FSFranscisca Soto-Aguliar
Franscisca Soto-Aguliar
LHLi Huang
Li Huang
WLWentao Li
Wentao Li
SXShifen Xu
Shifen Xu
Vascular cognitive impairment with no dementia (VCIND), manifested mainly as mild impairment of concentration and executive function, is the early phase of vascular dementia (VD). Currently, there is no specific treatment for VCIND. We hypothesize that electrical acupuncture can improve the mental and motor functions of patients with VCIND. Thus, we designed this randomized controlled trial to test this hypothesis by comparing the therapeutic effect of electrical acupuncture versus sham acupuncture in patients with VCIND. In this single-center 3-year study, 120 eligible patients will be recruited and randomly assigned to receive electrical acupuncture treatment (n = 60) or sham acupuncture (n = 60) for 8 consecutive weeks (24 sessions in total), with the same acupoint prescription (DU20, EX-HN3, DU24, DU17, DU26, EX-HN1, HT7, PC6, GB20, SP6). The primary assessment is the Montreal Cognitive Assessment. The secondary assessments are the Modified Barthel Index and Event-Related Potential. All outcomes will be assessed at baseline, endpoint, and follow-up at 8 and 24 weeks after the end of treatment. If the outcome confirms the effectiveness and safety of electrical acupuncture in treating VCIND, this treatment is expected to be promoted in clinical practice to treat such patients. Chinese Clinical Trial Registry identifier: ChiCTR-IIR-17011513 ; Registered on 27 May 2017.

31 July 2019 in Trials
Verified
Journal Article
Open access
PDF file
TLTian Li
Tian Li
SWSiyao Wang
Siyao Wang
SZShen Zhang
Shen Zhang
XSXue Yong Shen
Xue Yong Shen
YSYanwen Song
Yanwen Song
ZHZouqin Huang
Zouqin Huang
As a common cause of low back pain, lumbosacral disc herniation (LDH) is usually dealt with using non-surgical interventions. In the face of concerns about prescription opioid abuse, alternative and complementary treatments may be promising, among which silver-needle warm acupuncture is considered as an upgrading option for its potential anti-inflammatory and strong analgesic effect for patients with chronic pain. In this proposed study, we aim to assess its clinical efficacy in comparison with conventional stainless steel filiform-needle warm acupuncture. This is a randomized, two-armed, patient- and assessor-blinded trial. One hundred and sixty eligible patients recruited from December 2018 to June 2020 in three centers will be assigned for warm acupuncture treatment with either stainless steel filiform or silver needles. Nine sessions of 20-min treatment will be conducted during 3 consecutive weeks. Assessments with instruments including the Oswestry Disability Index, the visual analog scale, and the Japanese Orthopedic Association Back Pain Evaluation Questionnaire will be performed at four time points to explore the difference of clinical efficacy between two groups. If the results show that participants treated with silver-needle warm acupuncture gain a greater improvement in terms of pain intensity, physical function, and quality of life, this study is expected to offer reliable evidence to widely push this treatment for LDH in clinical practice. Chinese Clinical Trial Registry, ChiCTR1800019051 . Registered on 24 October 2018.

1 March 2022 in Integrative Medicine Research
Verified
Journal Article
Open access
TLTian Li
Tian Li
SWSiyao Wang
Siyao Wang
KCKe Cheng
Ke Cheng
LSLu Sun
Lu Sun
DJDaopeng Jin
Daopeng Jin
ZHZouqin Huang
Zouqin Huang
Warm acupuncture, a combination of the mechanical stimulation of acupuncture and thermal stimulation of moxibustion, is commonly used in treating acute low back pain (LBP). This trial aimed to compare the efficacy of stronger (above 43°C) and weaker (above 40°C) heat stimulation in warm acupuncture on the function and pain in patients with acute LBP due to lumbosacral disc degeneration (LDD). One hundred and fifty-nine adults were randomly assigned to receive warm acupuncture treatment with silver needle (SvN) or with stainless steel needle (SSN) (1:1). Both groups received a 3-week therapy with 3 sessions per week. The primary outcome was the modified Oswestry Disability Index at week 4. The secondary outcomes included average pain, three physical sign tests and adverse events. Participants were followed up at week 16 and week 28 after randomization. The LBP related disability and pain intensity significantly relieved more in the SvN warm acupuncture group than in the SSN group, in both the short and long term (p<0.001). The between-groups difference in physical signs showed statistical significance only in the short term (p = 0.024), but not in long term (p = 0.081; p = 0.069). Compared with warm acupuncture with stainless-steel needle at above 40°C, warm acupuncture with silver needle at above 43°C relieved more disability and pain in patients with acute LBP due to LDD. Chinese Clinical Trial Registry (ChiCTR1800019051)

1 February 2018 in Urology
Verified
Journal Article
Closed access
TLTian Li
Tian Li
XFXiaoming Feng
Xiaoming Feng
JLJianwei Lv
Jianwei Lv
TCTianyao Cai
Tianyao Cai
SWSiyou Wang
Siyou Wang


24 November 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
TLTian Li
Tian Li
SWSiyou Wang
Siyou Wang
QCQi Chen
Qi Chen
TLTingting Lv
Tingting Lv
ZHZouqin Huang
Zouqin Huang
Electrical pudendal nerve stimulation (EPNS) has been proposed as a clinic-based option for post-prostatectomy incontinence (PPI), but comparative evidence is limited. We conducted a retrospective cohort study across three medical centers (2018–2022) comparing EPNS (24 sessions over eight weeks) with pelvic-floor muscle training plus transrectal electrical stimulation (PFMT + TES). Primary outcomes were changes from baseline to end of treatment in the International Consultation on Incontinence Questionnaire–Urinary Incontinence Short Form (ICIQ-UI SF) score and 24-hr pad-test urine loss. The Incontinence Impact Questionnaire-7 (IIQ-7) score was assessed as a secondary outcome, and pad-free status was recorded at six months after treatment. In adjusted analyses using propensity-score overlap weighting of 389 men, EPNS was associated with larger improvements than PFMT + TES in ICIQ-UI SF (β − 4.34, 95% CI − 6.65 to − 2.02), 24-hr pad-test urine loss (β − 631.26 g, − 750.81 to − 511.70), and IIQ-7 (β − 2.86, − 5.14 to − 0.58). Unweighted within-group changes were directionally consistent. At the last follow-up, pad-free status was observed in 32.6% of men in the EPNS group versus 7.0% with PFMT + TES. These findings suggest that eight weeks of EPNS can reduce symptom burden and urine loss and yield patient-perceivable quality-of-life gains, although further studies are needed to evaluate the long-term effects. Trial registration: ClinicalTrial.gov (NCT06130306 Registration Date 11/05/2023).